Antares Pharma

Antares Pharma EBIT per Share

Delisted

The EBIT per Share of Antares Pharma (ATRS) as of Nov 2, 2026 is 0.38 USD. In the previous year, EBIT per Share was 0.08 USD — a change of 367.24% (higher).

EBIT per Share

0.38USD

YoY

367.24%

Last updated:

EBIT per Share of Antares Pharma is 2021 0.38 USD. EBIT per Share of Antares Pharma was 2020 0.08 USD. It decreases by 367.24% higher compared to the previous year.

The Antares Pharma EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
0.01 USD
Jan 1, 2020
0.08 USD
Jan 1, 2021
0.38 USD
Jan 1, 2022 (e)
0.12 USD
Jan 1, 2023 (e)
0.30 USD
Jan 1, 2024 (e)
0.47 USD
Jan 1, 2025 (e)
0.94 USD
Jan 1, 2026 (e)
1.90 USD
The Antares Pharma EBIT per Share history
YEAREBIT per ShareYoY
est1.90USD+103.17%
est0.94USD+99.19%
est0.47USD+57.83%
est0.30USD+148.51%
est0.12USD-68.23%
0.38USD+367.24%
0.08USD+1,224.95%
0.01USD-124.88%
-0.02USD-75.09%
-0.10USD-36.88%
-0.16USD+11.78%
-0.14USD-48.07%
-0.27USD+63.26%
-0.16USD+57.70%
-0.10USD+127.60%
-0.05USD-37.00%
-0.07USD-45.32%
-0.13USD-26.81%
-0.18USD+25.08%
-0.15USD-9.60%
-0.16USD-22.55%
-0.21USD-10.08%
-0.23USD-59.72%
-0.57USD-46.38%
-1.07USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Antares Pharma Stock analysis

What does Antares Pharma do? The company Antares Pharma Inc was founded in 1979 in Minneapolis, USA. It has since become a successful company in the field of drug development and marketing. The company has been listed on the NASDAQ since 2006. Antares Pharma is a pharmaceutical company specializing in the development of injectable medications. Their business model is to develop innovative injectable products that meet the needs of patients and doctors, and are able to improve their therapy experience and increase adherence. The company specializes in three areas: self-injection systems, automatic devices, and pharmaceutical products. The innovation power behind Antares Pharma's development work is an important factor in their success, as well as their skills in market research and marketing. One of the company's main products is the VIBEX Pen, an automatic injection device that can be operated by patients themselves and filled with various therapeutics. The device provides an easy and painless way to administer medications. The company also produces the Makena auto-injector, which is used in pregnancy treatment. Another important product is the QuickShot auto-injector, a proprietary device used by patients to administer hormone preparations, immunomodulators, and various other common therapeutics. Due to its many years of experience and good reputation in the market, Antares Pharma has strong collaborative relationships with the pharmaceutical industry. The company's customers include reputable pharmaceutical companies such as Pfizer, Teva, Merck, and Novartis, who utilize the company's expertise to bring their own products to the market. Antares Pharma is headquartered in Ewing Township, New Jersey, USA. The company employs a variety of research and development experts who are constantly working to develop new medications and therapy approaches. It has strengthened its position as a major player in the pharmaceutical market and its goal remains to continue creating innovative solutions in the industry. Answer: Antares Pharma Inc. is a successful pharmaceutical company specializing in the development and marketing of injectable medications. They are known for their innovative products that improve therapy experiences and increase adherence. With a strong presence in the pharmaceutical market, Antares Pharma collaborates with renowned companies and continues to strive for innovative solutions. Antares Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Antares Pharma stock

EBIT per Share of Antares Pharma is 0.38 USD in 2021.

EBIT per Share of Antares Pharma changed from 0.08 USD to 0.38 USD, representing a 367.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Antares Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Antares Pharma

All Key Metrics — Antares Pharma